- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07697755
Interoceptive Intervention for Congenital Heart Disease
A Randomised Controlled Feasibility Trial Exploring an Interoceptive-Based Intervention in Patients With Congenital Heart Disease
Adults living with congenital heart disease (CHD) commonly experience physical symptoms alongside emotional and social challenges, which can affect wellbeing and health-related quality of life. Access to psychological services varies, and evidence to guide the development and delivery of psychological interventions for this population is still emerging.
Interoceptive-based approaches focus on increasing awareness of and responding adaptively to internal bodily sensations, such as breathing, heart rate and fatigue. These approaches have shown benefits in other long-term health conditions but have not yet been studied in adults with CHD. This study will evaluate the feasibility, acceptability, and preliminary effects of a newly adapted online, skills-based group programme for adults with CHD.
Thirty-two participants will be recruited through the Scottish Adult Congenital Cardiac Service and randomly allocated to one of two cohorts: Cohort 1 (Immediate Intervention) and Cohort 2 (Delayed/Waitlist Intervention). The group programme will consist of eight online sessions delivered by a Principal Clinical Psychologist and a Trainee Clinical Psychologist. Weekly sessions will explore the relationship between interoception and key areas relevant to living with CHD, including emotions, behaviours, and physical symptoms. Group discussions and exercises will focus on increasing awareness and understanding of internal bodily sensations, developing strategies for responding to interoceptive cues and using bodily information to guide behaviours and everyday activities.
Participants will complete online questionnaires before and after the intervention assessing interoception, anxiety, depression and health-related quality of life. Participants will also provide feedback regarding the acceptability and perceived usefulness of the programme. Participation is voluntary, and participants may withdraw at any time without affecting their clinical care. Appropriate emotional support will be available should participants experience distress related to the group materials or discussions.
Findings from this feasibility randomised controlled trial will inform further refinement of the group programme, assess the acceptability and feasibility of study procedures, provide estimates of recruitment, retention and outcome variability, and support the design and sample size calculation of a future definitive trial. The findings may also contribute to the enhancement of psychological support for adults with CHD and be disseminated through scientific publications and conference presentations.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Jason McBurnie
- Telefonnummer: +44 07710885146
- E-mail: 2272649m@student.gla.ac.uk
Undersøgelse Kontakt Backup
- Navn: Katja Weides
- E-mail: Katja.Weides@glasgow.ac.uk
Studiesteder
-
-
-
Glasgow, Det Forenede Kongerige, G81 4DY
- Golden Jubilee University National Hospital
-
Kontakt:
- Catherine Sinclair
- E-mail: catherine.sinclair@goldenjubilee.scot.nhs.uk
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Participants must be aged 18 years or older
- Under the care of the Scottish Adult Congenital Cardiac Service (SACCS) at the Golden Jubilee University National Hospital (GJUNH)
- Be able to understand and communicate in English
- Provide informed consent
- Access and use a device compatible with Microsoft Teams
- Be able to commit to the duration of the group programme
Exclusion Criteria:
- Individuals with current suicidal ideation
- Individuals with comorbid alcohol or substance use disorders
- Individuals with a diagnosed learning disability
- Individuals with a severe and enduring mental health condition (e.g., personality disorder or psychosis)
- Individuals with hearing, visual and cognitive difficulties preventing safe online group participation
- Individuals who are currently on a surgical or transplant waiting list
- Individuals who are receiving intensive psychological treatment (e.g., trauma processing or crisis support)
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Cohort 1 (Immediate Intervention)
An 8-week online group intervention where participants will learn skills to improve interoception and connect with their body.
|
An 8-week online group intervention aiming to improve interoception.
Andre navne:
|
|
Ingen indgriben: Cohort 2 (Delayed/Waitlist Intervention)
Participants will wait until Cohort 1 (Immediate Intervention) have completed the intervention before commencing themselves
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Multidimensional Assessment of Interoceptive Awareness (MAIA-2)
Tidsramme: Baseline (up to 4 weeks prior to intervention starting) and 8 weeks (during last intervention session)
|
The MAIA-2 is a 32-item self-report scale measuring eight concepts related to interoception: (1) attention regulation, (2) emotional awareness, (3) noticing, (4) self-regulation, (5) not-worrying, (6) not-distracting, (7) body listening and (8) trusting.
Items are answered on a six-point Likert scale ranging from 0 = Never to 5 = Always.
Each subscale is interpreted independently to reflect different aspects of interoceptive awareness, including in populations with long-term health conditions.
|
Baseline (up to 4 weeks prior to intervention starting) and 8 weeks (during last intervention session)
|
|
Feasibility and Acceptability Questionnaire
Tidsramme: At 8 weeks (during last intervention session)
|
This questionnaire will assess accessibility, delivery, group format/content, perceived usefulness of exercises and potential impact on anxiety, depression, health-related quality of life or interoception, using a five-point Likert scale (from 1= strongly disagree to 5 = strongly agree).
Participants will indicate if they would recommend the intervention and provide qualitative feedback.
|
At 8 weeks (during last intervention session)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
The Generalised Anxiety Disorders Scale (GAD-7)
Tidsramme: Baseline (up to 4 weeks prior to intervention starting) and 8 weeks (during last intervention session)
|
The GAD-7 is a 7-item self-report scale assessing the frequency and presence of anxiety symptoms over the past two weeks.
Items are rated on a four-point Likert scale, ranging from 0 = Not at all to 3 = Nearly every day.
Total scores range from 0 to 21, with higher scores indicating more severe anxiety symptoms.
It is widely validated in primary care and chronic health settings.
|
Baseline (up to 4 weeks prior to intervention starting) and 8 weeks (during last intervention session)
|
|
Patient Health Questionnaire 9 (PHQ-9)
Tidsramme: Baseline (up to 4 weeks prior to intervention starting) and 8 weeks (during last intervention session)
|
The PHQ-9 is a 9-item self-report scale assessing the frequency and presence of depressive symptoms over the past two weeks.
Items are rated on a four-point Likert scale, ranging from 0 = Not at all to 3 = Nearly every day.
Total scores range from 0 to 27, with higher scores indicating more severe depressive symptoms.
It is widely validated in primary care and chronic health settings.
|
Baseline (up to 4 weeks prior to intervention starting) and 8 weeks (during last intervention session)
|
|
Short Form Health Survey (SF-12)
Tidsramme: Baseline (up to 4 weeks prior to intervention starting) and 8 weeks (during last intervention session)
|
The SF-12 is a 12-item HRQoL self-report scale producing Physical and Mental Component Summary scores from eight domains: (1) physical functioning, (2) physical role limitations, (3) emotional role limitations, (4) bodily pain, (5) general health, (6) vitality, (7) social functioning and (8) mental health.
Scores range from 0 to 100; higher total scores indicate better health.
The SF-12 has been validated in cardiac populations as an alternative to its longer 36-item version.
|
Baseline (up to 4 weeks prior to intervention starting) and 8 weeks (during last intervention session)
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Publikationer og nyttige links
Generelle publikationer
- Mehling WE, Acree M, Stewart A, Silas J, Jones A. The Multidimensional Assessment of Interoceptive Awareness, Version 2 (MAIA-2). PLoS One. 2018 Dec 4;13(12):e0208034. doi: 10.1371/journal.pone.0208034. eCollection 2018.
- Lowe B, Decker O, Muller S, Brahler E, Schellberg D, Herzog W, Herzberg PY. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008 Mar;46(3):266-74. doi: 10.1097/MLR.0b013e318160d093.
- Lowe B, Kroenke K, Herzog W, Grafe K. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord. 2004 Jul;81(1):61-6. doi: 10.1016/S0165-0327(03)00198-8.
- Muller-Nordhorn J, Roll S, Willich SN. Comparison of the short form (SF)-12 health status instrument with the SF-36 in patients with coronary heart disease. Heart. 2004 May;90(5):523-7. doi: 10.1136/hrt.2003.013995.
- Heim N, Bobou M, Tanzer M, Jenkinson PM, Steinert C, Fotopoulou A. Psychological interventions for interoception in mental health disorders: A systematic review of randomized-controlled trials. Psychiatry Clin Neurosci. 2023 Oct;77(10):530-540. doi: 10.1111/pcn.13576. Epub 2023 Aug 9.
- Moons P, Van Bulck L, Daelman B, Luyckx K. Mental health in adult congenital heart disease. Int J Cardiol Congenit Heart Dis. 2023 Apr 1;12:100455. doi: 10.1016/j.ijcchd.2023.100455. eCollection 2023 Jun.
- Kovacs AH, Brouillette J, Ibeziako P, Jackson JL, Kasparian NA, Kim YY, Livecchi T, Sillman C, Kochilas LK; American Heart Association Council on Lifelong Congenital Heart Disease and Heart Health in the Young; and Stroke Council. Psychological Outcomes and Interventions for Individuals With Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circ Cardiovasc Qual Outcomes. 2022 Aug;15(8):e000110. doi: 10.1161/HCQ.0000000000000110. Epub 2022 Jul 14.
- Kovacs AH, Luyckx K, Thomet C, Budts W, Enomoto J, Sluman MA, Lu CW, Jackson JL, Khairy P, Cook SC, Chidambarathanu S, Alday L, Estensen ME, Dellborg M, Berghammer M, Johansson B, Mackie AS, Menahem S, Caruana M, Veldtman G, Soufi A, Jameson SM, Callus E, Kutty S, Oechslin E, Van Bulck L, Moons P; APPROACH-IS Consortium, International Society for Adult Congenital Heart Disease. Anxiety and Depression in Adults With Congenital Heart Disease. J Am Coll Cardiol. 2024 Jan 23;83(3):430-441. doi: 10.1016/j.jacc.2023.10.043.
- Moore, D. (2025). Exploring the contribution of psychology in the self-management of pulmonary hypertension (Doctoral dissertation, University of Glasgow).
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- IRAS ID: 367530
- 26/SC/0144 (Anden identifikator: Health Research Authority (HRA))
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Medfødt hjertesygdom
-
Fondation Hôpital Saint-JosephRekruttering
-
Region SkaneTilmelding efter invitationHjertesvigt New York Heart Association (NYHA) klasse II | Hjertesvigt New York Heart Association (NYHA) klasse IIISverige
-
Opus Genetics, IncIkke rekrutterer endnuLeber medfødt amaurose | Leber Congenital Amaurosis (LCA) | LCA5Forenede Stater
-
Medical University of BialystokMedical University of Lodz; Poznan University of Medical Sciences; Nicolaus... og andre samarbejdspartnereAfsluttetHjertesvigt, systolisk | Hjertesvigt med reduceret udstødningsfraktion | Hjertesvigt New York Heart Association Klasse IV | Hjertesvigt New York Heart Association Klasse IIIPolen
-
V-Wave LtdJohnson & JohnsonIkke rekrutterer endnuHjertesvigt Kongestiv | Hjertesvigt og reduceret ejektionsfraktion | Hjertesvigt New York Heart Association Klasse III | Heart Failure Chronic
-
University of WashingtonAmerican Heart AssociationAfsluttetHjertesvigt, Kongestiv | Mitokondriel ændring | Hjertesvigt New York Heart Association Klasse IVForenede Stater
-
Portuguese Association of Interventional CardiologyMedtronicRekrutteringSvær Symptomatisk Aortastenose (Defineret som New York Heart Association (NYHA) klasse ≥ II)Portugal
-
Novartis PharmaceuticalsAfsluttetPatienter, der med succes afslutter den 12-måneders behandlingsperiode i kernestudiet (de Novo Heart-modtagere), som var interesserede i at blive behandlet med EC-MPS
-
Instituto de Genética OcularAktiv, ikke rekrutterende
-
University Hospital, GasthuisbergUkendtTransient Left Ventricular Ballooning SyndromeBelgien
Kliniske forsøg med Interoceptive-Based Group Intervention
-
Washington University School of MedicineSpinal Cord Injury/Disease Research ProgramAfsluttet
-
Albert Einstein College of MedicineHealth Resources and Services Administration (HRSA); The New SchoolAfsluttetVold i hjemmet | BørnemishandlingForenede Stater
-
Golden Jubilee National HospitalRekrutteringPulmonal hypertension | InteroceptionDet Forenede Kongerige
-
National Healthcare Group PolyclinicsInstitute of Mental Health, Singapore; Lee Kong Chian School of Medicine... og andre samarbejdspartnereIkke rekrutterer endnuMentalt helbred | Trivsel/LivskvalitetSingapore
-
Medipol UniversityAfsluttetHyperkyfose | Kyphose ThoracicKalkun
-
University of PaviaUniversità degli Studi di BresciaAfsluttetMentalt velværeItalien
-
Stockholm UniversityKarolinska Institutet; Region Stockholm; Centrum för kompetensutveckling... og andre samarbejdspartnereAktiv, ikke rekrutterende
-
University of Nevada, Las VegasIkke rekrutterer endnuPost traumatisk stress syndrom
-
University of California, Los AngelesBrown University; Asociación Civil Impacta Salud y Educación, Peru; The Fenway...Afsluttet